Entera Bio Ltd.
For the period ended Dec 31, 2025. Filed Mar 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 27, 2026
ENTX$3.24-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
AS OF DECEMBER 31, 2025
TABLE OF CONTENTS
| Page | |
|---|---|
| REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID 1309) | 92 |
| CONSOLIDATED FINANCIAL STATEMENTS: | |
| Consolidated Balance Sheets | 94 |
| Consolidated Statements of Operations | 95 |
| Consolidated Statements of Changes in Shareholders' Equity | 96 |
| Consolidated Statements of Cash Flows | 97 |
| Notes to the Consolidated Financial Statements | 98 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.